Immune checkpoint inhibitor combinations—current and emerging strategies von Walsh, Robert J., Sundar, Raghav, Lim, Joline S. J.

Volltext

Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma von Yong, Kol Jia, Gao, Chong, Lim, Joline S.J, Yan, Benedict, Yang, Henry, Dimitrov, Todor, Kawasaki, Akira, Ong, Chee Wee, Wong, Kwong-Fai, Lee, Sanghoon, Ravikumar, Sharada, Srivastava, Supriya, Tian, Xi, Poon, Ronnie T, Fan, Sheung Tat, Luk, John M, Dan, Yock Young, Salto-Tellez, Manuel, Chai, Li, Tenen, Daniel G

Volltext

Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials von Loh, Jerold, Wu, Jiaxuan, Chieng, Jenny, Chan, Aurora, Yong, Wei-Peng, Sundar, Raghav, Lee, Soo-Chin, Wong, Andrea, Lim, Joline S. J., Tan, David S. P., Soo, Ross, Goh, Boon-Cher, Tai, Bee-Choo, Chee, Cheng E.

Volltext

Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases von Chia, Daryl K. A., Sundar, Raghav, Kim, Guowei, Ang, Jia Jun, Lum, Jeffrey H. Y., Nga, Min En, Goh, Giap Hean, Seet, Ju Ee, Chee, Cheng Ean, Tan, Hon Lyn, Ho, Jingshan, Ngoi, Natalie Y. L., Lee, Matilda X. W., Muthu, Vaishnavi, Chan, Gloria H. J., Pang, Angela S. L., Ang, Yvonne L. E., Choo, Joan R. E., Lim, Joline S. J., Teh, Jun Liang, Lwin, Aung, Soon, Yuen, Shabbir, Asim, So, Jimmy B. Y., Yong, Wei Peng

Volltext

Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence von Lim, Joline S. J., Soo, Ross A.

Volltext

A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours von Ang, Yvonne L E, Ho, Gwo Fuang, Soo, Ross A, Sundar, Raghav, Tan, Sing Huang, Yong, Wei Peng, Ow, Samuel G W, Lim, Joline S J, Chong, Wan Qin, Soe, Phyu Pyar, Tai, Bee Choo, Wang, Lingzhi, Goh, Boon Cher, Lee, Soo-Chin

Volltext

Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer von Zhao, Joseph J, Fong, Khi Yung, Chan, Yiong Huak, Tey, Jeremy, Dawood, Shaheenah, Lee, Soo Chin, Finn, Richard S, Sundar, Raghav, Lim, Joline S J

Volltext

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies von Chee, Cheng E., Ooi, Melissa, Lee, Soo-Chin, Sundar, Raghav, Heong, Valerie, Yong, Wei-Peng, Ng, Chin Hin, Wong, Andrea, Lim, Joline S. J., Tan, David S. P., Soo, Ross, Tan, Joshua T. C., Yang, Song, Thura, Min, Al-Aidaroos, Abdul Qader, Chng, Wee Joo, Zeng, Qi, Goh, Boon-Cher

Volltext

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors von Lee, Matilda Xinwei, Wong, Andrea L. A., Ow, Samuel, Sundar, Raghav, Tan, David S. P., Soo, Ross A., Chee, Cheng Ean, Lim, Joline S. J., Yong, Wei Peng, Lim, Siew Eng, Goh, Boon Cher, Wang, Lingzhi, Lee, Soo Chin

Volltext

A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma von Kong, Li Ren, Mohamed Salleh, Nur Afiqah Binte, Ong, Richard Weijie, Tan, Tuan Zea, Syn, Nicholas L., Goh, Robby Miguel, Fhu, Chee Wai, Tan, Daniel S. W., Iyer, N. Gopalakrishna, Kannan, Srinivasaraghavan, Verma, Chandra S., Lim, Yaw Chyn, Soo, Ross, Ho, Jingshan, Huang, Yiqing, Lim, Joline S. J., Yan, Benedict Junrong, Nga, Min En, Lim, Seng Gee, Koeffler, H. Phillip, Lee, Soo Chin, Kappei, Dennis, Hung, Huynh The, Goh, Boon Cher

Volltext

Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors von Choo, Joan R. E., Jan, Yi-Hua, Ow, Samuel G. W., Wong, Andrea, Lee, Matilda Xinwei, Ngoi, Natalie, Yadav, Kritika, Lim, Joline S. J., Lim, Siew Eng, Chan, Ching Wan, Hartman, Mikael, Tang, Siau Wei, Goh, Boon Cher, Tan, Hon Lyn, Chong, Wan Qin, Yvonne, Ang Li En, Chan, Gloria H. J., Chen, Shu-Jen, Tan, Kien Thiam, Lee, Soo Chin

Volltext

Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics von Collins, Dearbhaile C, Sundar, Raghav, Lim, Joline S.J, Yap, Timothy A

Volltext

Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors von Yap, Timothy A, O'Carrigan, Brent, Penney, Marina S, Lim, Joline S, Brown, Jessica S, de Miguel Luken, Maria J, Tunariu, Nina, Perez-Lopez, Raquel, Rodrigues, Daniel Nava, Riisnaes, Ruth, Figueiredo, Ines, Carreira, Suzanne, Hare, Brian, McDermott, Katherine, Khalique, Saira, Williamson, Chris T, Natrajan, Rachael, Pettitt, Stephen J, Lord, Christopher J, Banerji, Udai, Pollard, John, Lopez, Juanita, de Bono, Johann S

Volltext

Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2 - and Non- BRCA1/2 -Mutant Cancers von Yap, Timothy A, Kristeleit, Rebecca, Michalarea, Vasiliki, Pettitt, Stephen J, Lim, Joline S J, Carreira, Suzanne, Roda, Desamparados, Miller, Rowan, Riisnaes, Ruth, Miranda, Susana, Figueiredo, Ines, Rodrigues, Daniel Nava, Ward, Sarah, Matthews, Ruth, Parmar, Mona, Turner, Alison, Tunariu, Nina, Chopra, Neha, Gevensleben, Heidrun, Turner, Nicholas C, Ruddle, Ruth, Raynaud, Florence I, Decordova, Shaun, Swales, Karen E, Finneran, Laura, Hall, Emma, Rugman, Paul, Lindemann, Justin P O, Foxley, Andrew, Lord, Christopher J, Banerji, Udai, Plummer, Ruth, Basu, Bristi, Lopez, Juanita S, Drew, Yvette, de Bono, Johann S

Volltext

Targeting Cell Metabolism as Cancer Therapy von Ngoi, Natalie Y L, Eu, Jie Qing, Hirpara, Jayshree, Wang, Lingzhi, Lim, Joline S J, Lee, Soo-Chin, Lim, Yaw-Chyn, Pervaiz, Shazib, Goh, Boon Cher, Wong, Andrea L A

Volltext

Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers von Lee, Soo-Chin, Shimasaki, Noriko, Lim, Joline S J, Wong, Andrea, Yadav, Kritika, Yong, Wei Peng, Tan, Lip Kun, Koh, Liang Piu, Poon, Michelle L M, Tan, Sing Huang, Ow, Samuel G W, Bharwani, Lavina, Yap, Yoon Sim, Foo, Mabel Z Q, Coustan-Smith, Elaine, Sundar, Raghav, Tan, Hon Lyn, Chong, Wan Qin, Kumarakulasinghe, Nesaretnam Barr, Lieow, Jedidah L M, Koe, Priscillia J X, Goh, Boon Cher, Campana, Dario

Volltext

Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA -Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers von Pascual, Javier, Lim, Joline S J, Macpherson, Iain R, Armstrong, Anne C, Ring, Alistair, Okines, Alicia F C, Cutts, Rosalind J, Herrera-Abreu, Maria Teresa, Garcia-Murillas, Isaac, Pearson, Alex, Hrebien, Sarah, Gevensleben, Heidrun, Proszek, Paula Z, Hubank, Michael, Hills, Margaret, King, Jenny, Parmar, Mona, Prout, Toby, Finneran, Laura, Malia, Jason, Swales, Karen E, Ruddle, Ruth, Raynaud, Florence I, Turner, Alison, Hall, Emma, Yap, Timothy A, Lopez, Juanita S, Turner, Nicholas C

Volltext

Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors von Lim, Joline S J, Tan, David S P

Volltext

CDK4/6 Inhibitors: Promising Opportunities beyond Breast Cancer von Lim, Joline S J, Turner, Nicholas C, Yap, Timothy A

Volltext

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer von Lim, Joline S J, Wong, Andrea L A, Ow, Samuel G W, Ngoi, Natalie Y L, Chan, Gloria H J, Ang, Yvonne L E, Chong, Wan Qin, Lim, Siew Eng, Lim, Yi Wan, Lee, Matilda, Choo, Joan R E, Tan, Hon Lyn, Yong, Wei Peng, Soo, Ross A, Tan, David S P, Chee, Cheng Ean, Sundar, Raghav, Yadav, Kritika, Jain, Supriya, Wang, Lingzhi, Tai, Bee Choo, Goh, Boon Cher, Lee, Soo-Chin

Volltext